Swan Defence H1FY27 Results (NSE: SWANDEF)
Signal: Steady quarter
The read
The operating inflection is real but still early: H1 revenue reached ₹99.46 Cr, +148.7% YoY, and the firm order book stands at approximately ₹6,500 Cr with stated revenue visibility through FY31; nevertheless, PAT of ₹524.78 Cr alongside PBT loss of ₹38.37 Cr is a major earnings-quality disconnect that must be reconciled before the execution story can be judged on recurring profitability.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹99.46 Cr | +148.7% | N/A |
| Net profit | ₹524.78 Cr | N/A |
P&L walk
Revenue increased to ₹99.46 Cr from ₹39.99 Cr, +148.7% YoY, as the shipyard moved into scaled execution; however, PAT of ₹524.78 Cr contrasts with a PBT loss of ₹38.37 Cr, so the reported bottom line is not explained by operating performance in this filing.
Key positives
- Revenue from operations reached ₹99.46 Cr in H1 FY27, up 148.7% YoY from ₹39.99 Cr, consistent with management's stated transition from turnaround to scaled execution.
- Firm order book of approximately ₹6,500 Cr provides stated revenue visibility through FY31, with expected completion of 6% in FY27, 23% in FY28 and 65% in FY29.
- The company secured export orders for six chemical tankers, four ammonia dual-fuel bulk carriers and four harbour tugs, while completing seven ship repair and refit projects in H1 FY27.
- The shipyard has received in-principle approval for brownfield expansion with 25% capital assistance and a 3% interest incentive on eligible expansion financing.
Key concerns
- PAT of ₹524.78 Cr is inconsistent with PBT loss of ₹38.37 Cr; the supplied filing does not explain the below-PBT item driving the reported profit.
- Operating profitability remains unproven: the filing does not disclose EBITDA, EBIT or operating margin for H1 FY27, while the company was still loss-making at the PBT level.
- The ₹6,500 Cr order book is heavily back-ended, with only 6% expected to be completed in FY27 and 23% by FY28, leaving near-term conversion dependent on execution ramp-up.
- The planned 550+ additional hires by March 2027 increase execution capacity but also raise the need to monitor fixed-cost absorption before recurring margins are visible.
Research and educational content only. Not investment advice.